NRx Pharmaceuticals (NRXP) News Today $3.48 -0.17 (-4.66%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$3.46 -0.02 (-0.57%) As of 04:33 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRXP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period NRx Pharmaceuticals' (NRXP) Buy Rating Reaffirmed at D. Boral CapitalJune 8, 2025 | americanbankingnews.comIBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic NetworkJune 6, 2025 | finance.yahoo.comNRx Pharmaceuticals' (NRXP) "Buy" Rating Reaffirmed at D. Boral CapitalD. Boral Capital reaffirmed a "buy" rating and set a $31.00 target price on shares of NRx Pharmaceuticals in a report on Friday.June 6, 2025 | marketbeat.comIBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Files ANDA for Preservative-Free IV KetamineJune 5, 2025 | finance.yahoo.comNew to The Street Signs National Media Agreement with NRx Pharmaceuticals for 12-Part Broadcast Series Across TV, Digital, and Outdoor PlatformsJune 5, 2025 | usatoday.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV KetamineJune 5, 2025 | prnewswire.comIBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Announces $10.3M Financing to Expand HOPE Clinic Network, Advances FDA Drug ApprovalMay 29, 2025 | finance.yahoo.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Acquires Kadima Institute to Launch $100M Psychiatry Clinic NetworkMay 28, 2025 | msn.comIBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) to Present at Wall Street Conference on May 21May 21, 2025 | finance.yahoo.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc. Selected to Present at the Wall Street Conference on May 21, 2025, in Palm Beach, FloridaMay 21, 2025 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q1 2025 Earnings Call TranscriptMay 20, 2025 | msn.comNRx Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call TranscriptMay 16, 2025 | seekingalpha.comIBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Set to Report Q1 Earnings in Wake of HOPE's Strategic Kadima AgreementMay 16, 2025 | finance.yahoo.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 15, 2025 | prnewswire.comHOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic AcquisitionsMay 15, 2025 | prnewswire.comIBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire Kadima Neuropsychiatry InstituteMay 13, 2025 | finance.yahoo.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute; Foundational Acquisition for the HOPE Network of Interventional Psychiatry ClinicsMay 13, 2025 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May ...May 12, 2025 | gurufocus.comNRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May ...May 12, 2025 | gurufocus.comNRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025May 12, 2025 | prnewswire.comNRx Pharmaceuticals seeks patent for preservative-free ketamineMay 6, 2025 | investing.comIBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Files Patent for Preservative-Free Ketamine FormulationMay 6, 2025 | finance.yahoo.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. ...May 6, 2025 | gurufocus.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. ...May 6, 2025 | gurufocus.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025May 6, 2025 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Patent Application for NRX-100, its Proprietary, Preservative Free Formulation of IV KetamineMay 5, 2025 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming ...April 30, 2025 | gurufocus.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming ...April 30, 2025 | gurufocus.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc.to Participate in an H.C. Wainwright @ Home Fireside Discussion on Tuesday, April 22, 2025April 21, 2025 | prnewswire.comBTIG Initiates Coverage of NRx Pharmaceuticals (NRXP) with Buy RecommendationApril 3, 2025 | msn.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPEApril 3, 2025 | prnewswire.comNRx Pharmaceuticals initiated with a Buy at BTIGApril 3, 2025 | markets.businessinsider.comNRx Pharmaceuticals’ Hope Therapeutics to acquire Dura Medical, no termsApril 1, 2025 | markets.businessinsider.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Definitive Purchase Agreement with Dura Medical; Initial Acquisition for Planned International Network of Interventional Psychiatry ClinicsMarch 31, 2025 | prnewswire.comNRx Pharmaceuticals, HOPE Therapeutics sign binding LOI with NeurospaMarch 24, 2025 | markets.businessinsider.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Letter of Intent with Neurospa TMS Holdings, LLC for Expansion of its Planned International Network of Interventional Psychiatry ClinicsMarch 24, 2025 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2024 Earnings Call TranscriptMarch 21, 2025 | msn.comNRx Pharmaceuticals, Inc. (NRXP) Q4 2024 Earnings Call TranscriptMarch 17, 2025 | seekingalpha.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateMarch 17, 2025 | prnewswire.comNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 17, 2025March 12, 2025 | prnewswire.comNRx Pharmaceuticals, Inc. (NRXP): Among the Best Psychedelic Stocks to Buy in 2025March 1, 2025 | insidermonkey.comThe Therapeutic Potential and Investment Boom in Psychedelic MedicineMarch 1, 2025 | uk.finance.yahoo.comNRx Pharmaceuticals, Inc. (NRXP): Among the Best Psychedelic Stocks to Buy in 2025March 1, 2025 | msn.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc. to Present at the Oppenheimer 35th Annual Healthcare Conference on February 12, 2025February 6, 2025 | prnewswire.comNRx Pharmaceuticals, Hope Therapeutics engage BTIG as financial advisorFebruary 3, 2025 | markets.businessinsider.comHOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial AdvisorFebruary 3, 2025 | prnewswire.comNRx Pharmaceuticals invests $27M in subsidiary Hope for clinic acquisitionsJanuary 29, 2025 | markets.businessinsider.comNRx Pharmaceuticals announces $3.5M registered direct offeringJanuary 29, 2025 | markets.businessinsider.comBiotech Soars On Large Investment Announcement Into Its SubsidiaryJanuary 28, 2025 | msn.comHOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Execute Agreement for $27 Million Funding Transaction for HOPE Clinic AcquisitionJanuary 28, 2025 | prnewswire.com Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Email Address NRXP Media Mentions By Week NRXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRXP News Sentiment▼0.540.90▲Average Medical News Sentiment NRXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRXP Articles This Week▼82▲NRXP Articles Average Week Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Monopar Therapeutics News Eledon Pharmaceuticals News Esperion Therapeutics News Voyager Therapeutics News Journey Medical News DiaMedica Therapeutics News Organigram News Cybin News 4D Molecular Therapeutics News Silence Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRXP) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NRXP Stock Free NRXP Stock Alerts